Interní Med. 2011; 13(5): 202-204

Secondary prevention following myocardial infarction - regimen measures and pharmacological approaches

prof.MUDr.Jiří Vítovec, CSc., FESC1, prof.MUDr.Lenka ©pinarová, Ph.D., FESC2, prof.MUDr.Jindřich ©pinar, CSc., FESC1
1 I. interní kardioangiologická klinika, LF MU a FN u svaté Anny, Brno
2 Interní kardiologická klinika, LF MU a FN Brno

The article presents a basic overview of the interventions in a patient after acute myocardial infarction which, at present, is managed

predominantly by coronary angioplasty with stent implantation. In nonpharmacological approach, emphasis is placed on complete

smoking cessation, modifications in dietary habits and rehabilitation programmes. In pharmacotherapy, basic drug groups are listed

which should be used by a patient after myocardial infarction and for which clear mortality data from clinical studies are available – antiplatelet

therapy, hypolipidaemic drugs, beta blockers and drugs affecting the renin-angiotensin-aldosterone (RAA) system.

system.

Keywords: myocardial infarction, dietary measures, rehabilitation, antiaggregation, statins, beta blockers, drugs inhibiting the RAA

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J, ©pinarová L, ©pinar J. Secondary prevention following myocardial infarction - regimen measures and pharmacological approaches. Interní Med. 2011;13(5):202-204.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Widimský P, Hlinomaz O, Kala P, Jirmář R. Diagnostika a léčba akutního infarktu myokardu s elevacemi ST. Cor Vasa 2009; 51: 724-740. Go to original source...
    2. Bělohlávek J, Aschermann M. Doporučený postup pro diagnostiku a léčbu akutních koronárních syndromů bez elevací ST úseků na EKG. Cor Vasa 2008; 50(Suppl.): 1S7-1S23.
    3. Chaloupka V, Vaněk P, Juráň F, Leisser J. Nemocniční, posthospitalizační a lázeňská rehabilitace u nemocných s ICHS. Cor Vasa 1998; 40: K243-K251.
    4. Staněk V. Léčba srdečního infarktu. Cor Vasa 2002; 44: 207-208.
    5. ©pinar J, Vítovec J, a kol. Ischemická choroba srdeční. Praha: Grada 2003; 364 s.
    6. ©paček R, Widimský P. Infarkt myokardu. Praha: Galén 2003, 231 s.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.